Finance Operators cover image

How to lose $1.6B. Recent acquisitions in commerce, Tariff tactics & more.

Finance Operators

00:00

Navigating Financial Losses and Operational Inefficiencies

This chapter delves into a biotech company's $1.6 billion cumulative loss since its IPO, attributing it largely to excessive administrative and R&D expenses. It also humorously addresses common operational inefficiencies, concluding with a recommendation for a sponsor that aids in improving business operations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app